Be a Smart Investor
Monday, December 17, 2018
The Return Of OTC Asthma Inhaler Primatene Mist
After 7 years of absence, asthma inhaler Primatene Mist, developed by Amphastar Pharmaceuticals, is reentering the market with renewed features.
from RTT - Biotech https://ift.tt/2Bpwz34
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment